ANCP poster abstract publication with Janssen
OmniScience + Janssen abstract publication at the American College of Neuropsychopharmacology 61st Annual Meeting.
OmniScience announces the publication of collaborative work with the Janssen Neuroscience team at the 61st American College of Neuropsychopharmacology (ACNP) Annual Meeting.
This work furthers efforts to identify clinical subtypes and perform digital biomarker-based stratification in autism based on EEG, ECG, and other biosensors. These insights will be used to inform future clinical trial study designs. OmniScience is proud of this collaboration and shares special acknowledgment to Savannah Gosnell, PhD and Wen-Hsuan Chan, PhD for their expertise and involvement in this work.
Full poster abstracts linked as follows:
Case studies related to these poster abstracts:
P395
Connect with us
Our mission is to transform clinical trial operations to deliver life-changing medicines to patients faster. We built Vivo, the first agentic AI-powered control tower for clinical trials.
Vivo unifies fragmented clinical, safety, and operational data, and delivers real-time, explainable insights, putting teams ahead of the trial, not behind it. To learn more about Vivo, contact us at hello@omniscience.bio or connect with us on LinkedIn.
